Akcea Therapeutics Inc (AKCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKCA | SRPT | MESO | ||
| Company | Akcea Therapeutics Inc | Sarepta Therapeutics | Mesoblast Ltd ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 18.15 | 17.49 | 14.08 | ||
| High | 18.17 | 17.85 | 14.42 | ||
| Low | 18.13 | 17.25 | 14.07 | ||
| Latest | 18.17 | 17.61 | 14.32 | ||
| Change | +0.03 | -0.10 | +0.30 | ||
| % Change | +0.17% | -0.56% | +2.14% | ||
| Volume | 815,300 | 2,201,700 | 239,600 | ||
| 20-Day Average Volume | 661,490 | 2,620,915 | 350,825 | ||
| Previous Close | 18.14 | 17.71 | 14.02 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 18.14 | 17.00 | 15.13 | ||
| 20-Day Raw Stochastic | 70.59% | 55.97% | 22.87% | ||
| 20-Day Relative Strength | 73.10 | 47.87 | 39.53 | ||
| Weighted Alpha | -23.90 | -41.39 | -5.63 | ||
| Today's Opinion | 72% Buy | 88% Sell | 72% Sell | ||
| Previous Opinion | 64% Buy | 88% Sell | 72% Sell | ||
| Last Month's Opinion | 8% Buy | 88% Sell | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.22% since 10/02/20 | +4.57% since 03/17/26 | -1.45% since 03/17/26 | ||
| Low | 18.08 on 10/05/20 | 16.45 on 03/19/26 | 14.02 on 03/23/26 | ||
| High | 18.17 on 10/09/20 | 17.85 on 03/24/26 | 14.93 on 03/23/26 | ||
| 1-Month | |||||
| %Chg | +0.17% since 09/09/20 | -6.53% since 02/24/26 | -13.32% since 02/24/26 | ||
| Low | 18.05 on 09/21/20 | 15.52 on 03/06/26 | 13.45 on 03/03/26 | ||
| High | 18.22 on 09/28/20 | 19.25 on 02/25/26 | 17.25 on 02/26/26 | ||
| 3-Month | |||||
| %Chg | +36.72% since 07/09/20 | -21.10% since 12/24/25 | -26.19% since 12/24/25 | ||
| Low | 9.81 on 08/05/20 | 15.52 on 03/06/26 | 13.45 on 03/03/26 | ||
| High | 19.65 on 08/31/20 | 24.68 on 01/26/26 | 21.50 on 01/09/26 | ||
| 6-Month | |||||
| %Chg | +11.88% since 04/09/20 | -3.56% since 09/24/25 | -11.93% since 09/24/25 | ||
| Low | 9.81 on 08/05/20 | 15.08 on 11/04/25 | 13.45 on 03/03/26 | ||
| High | 19.65 on 08/31/20 | 25.32 on 10/08/25 | 21.50 on 01/09/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,846,054 | 1,859,373 | 1,809,001 | ||
| Shares Outstanding, K | 101,599 | 104,990 | 129,030 | ||
| Annual Sales | 488,540,000 | 2,198,240,000 | 17,200,000 | ||
| Annual Net Income | 40,770,000 | -713,410,000 | -102,140,000 | ||
| Last Quarter Sales | 22,380,000 | 442,930,000 | 1,930,000 | ||
| Last Quarter Net Income | -49,580,000 | -282,850,000 | -21,920,000 | ||
| 60-Month Beta | 1.45 | 0.42 | 2.17 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.49 on 08/04/20 | -3.58 on 02/25/26 | N/A on 09/06/19 | ||
| Latest Earnings Date | 11/03/20 | 05/05/26 | 02/26/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||